Kensuke Moriwaki
Kyoto, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 35 publications
Cost-effectiveness analysis of chemoradiotherapy compared to surgery in patients with stage I esophageal squamous cell carcinoma in Japan.
Journal: International journal of clinical oncology
Published: February 19, 2026
Cost-effectiveness analysis of low bone mass prevention in Chinese older men with excessive alcohol consumption: a modelling study.
Journal: BMJ open
Published: January 27, 2026
Comparative Cost-Effectiveness Analysis of Multiple First-Line Treatments for HER2-Negative Unresectable Advanced or Recurrent Gastric Cancer in Japan.
Journal: PharmacoEconomics - open
Published: July 04, 2025
Vignette-Based Estimation of Utilities in Patients With Metastatic Triple-Negative Breast Cancer in Japan.
Journal: Value in health regional issues
Published: June 18, 2025
Cost-Effectiveness of Pembrolizumab as First-Line Therapy for Advanced Colorectal Cancer With High Microsatellite Instability or Mismatched Repair Deficiency in Japan.
Journal: Value in health regional issues
Published: June 18, 2025
Cost-effectiveness analysis of pembrolizumab plus chemotherapy versus chemotherapy as first line chemotherapy for patients with unresectable advanced esophageal cancer in Japan.
Journal: Esophagus : official journal of the Japan Esophageal Society
Published: April 15, 2025
Cost-Effectiveness of Fracture Prevention in Postmenopausal Women With Early Breast Cancer in China.
Cost-Effectiveness of Fracture Prevention in Postmenopausal Women With Early Breast Cancer in China.
Journal: Journal of cachexia, sarcopenia and muscle
Published: February 19, 2025
Cost-effective analysis of transcatheter aortic valve replacement in patients with severe symptomatic aortic stenosis: A prospective multicenter study.
Journal: Journal of cardiology
Published: March 30, 2023
Cost-Effectiveness Analysis of Nivolumab Plus Ipilimumab Combination Therapy as First-line Treatment for Advanced Renal Cell Carcinoma in Japan.
Journal: Value in health regional issues
Published: February 21, 2023
Cost-effectiveness analysis of nivolumab plus chemotherapy vs chemotherapy for patients with unresectable advanced or metastatic HER2-negative gastric or gastroesophageal junction or esophageal adenocarcinoma in Japan.
Journal: Journal of gastroenterology
Published: January 14, 2023
Cost-Effectiveness Analysis of Universal Screening for Biliary Atresia in Japan.
Journal: The Journal of pediatrics
Published: June 20, 2022
Last Updated: 09/26/2026